other

Updated:

Sartorius Stedim Biotech S.A./ADR

Sartorius Stedim Biotech S.A./ADR is an American Depositary Receipt program that represents ownership in shares of Sartorius Stedim Biotech, a French-based...

Sartorius Stedim Biotech S.A./ADR

Sartorius Stedim Biotech S.A./ADR is an American Depositary Receipt program that represents ownership in shares of Sartorius Stedim Biotech, a French-based subsidiary of the Sartorius Group. The group supplies lab instruments and bioprocess equipment, with manufacturing sites in Germany, France, Puerto Rico, and China, and sales concentrated in Europe, North America, and Asia. The ADR enables US investors to trade the underlying shares on over-the-counter markets in dollar terms, without independent management, investment discretion, or portfolio activity beyond the sponsor’s administrative functions.

General information

Firm type

other

Sector focus

BiotechLife Sciences

Frequently asked questions

What is Sartorius Stedim Biotech S.A./ADR?

Sartorius Stedim Biotech S.A./ADR is a other tracked on Altss.

What does Altss track for Sartorius Stedim Biotech S.A./ADR?

Altss maintains an OSINT-verified profile of Sartorius Stedim Biotech S.A./ADR covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.

What is Sartorius Stedim Biotech S.A./ADR's website?

Sartorius Stedim Biotech S.A./ADR's public website is sartorius.com. Verified contact details for principals and decision-makers are available to Altss subscribers.

What type of firm is Sartorius Stedim Biotech S.A./ADR?

Sartorius Stedim Biotech S.A./ADR is classified by Altss as a other.

How does Altss source intelligence on Sartorius Stedim Biotech S.A./ADR?

Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.

When was Sartorius Stedim Biotech S.A./ADR's Altss profile last updated?

Sartorius Stedim Biotech S.A./ADR's profile on Altss was last refreshed on July 11, 2026. Continuous updates are applied as new public information is verified.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More other profiles